MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation

Praveen K. Bommareddy, Salvatore Aspromonte, Andrew Zloza, Samuel D. Rabkin, Howard L. Kaufman

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry